91 related articles for article (PubMed ID: 8528997)
1. Oxygen-derived free radicals in kidney in experimental hemorrhagic shock treated by PAF-receptor antagonist BN 52021.
Kirejczyk JK; Debek W; Dziecioł J; Chyczewski L; Makarewicz M; Nikliński J
Rocz Akad Med Bialymst; 1995; 40(1):77-87. PubMed ID: 8528997
[TBL] [Abstract][Full Text] [Related]
2. Ginkgolide BN 52021 protects against hemorrhagic shock-induced renal injury in rats.
Kirejczyk JK; Chyczewski L; Debek W
Rocz Akad Med Bialymst; 1995; 40(1):65-76. PubMed ID: 8528996
[TBL] [Abstract][Full Text] [Related]
3. Luminol-chemiluminescence in free peritoneal cells in hemorrhagic shock in rats treated with PAF-receptor-antagonist BN 52021.
Debek W; Gruca P; Chyczewski L; Gruca A
Rocz Akad Med Bialymst; 1995; 40(1):129-37. PubMed ID: 8528982
[TBL] [Abstract][Full Text] [Related]
4. BN 52021, PAF-receptor antagonist, improves diminished antioxidant defense system of lungs in experimentally induced haemorrhagic shock.
Makarewicz-Płońska M; Witek A; Farbiszewski R
Pol J Pharmacol; 1998; 50(3):265-9. PubMed ID: 9861635
[TBL] [Abstract][Full Text] [Related]
5. Role of platelet-activating factor in hepatocellular Ca2+ alterations during hemorrhagic shock.
Silomon M; Pizanis A; Larsen R; Rose S
J Surg Res; 1997 Oct; 72(2):101-6. PubMed ID: 9356229
[TBL] [Abstract][Full Text] [Related]
6. Role of reperfusion with polyelectrolyte solution and BN 52021 in hemorrhagic shock-induced changes in rat lungs.
Makarewicz-Płońska M; Skrzydlewska E; Farbiszewski R
Pol J Pharmacol; 1999; 51(2):137-42. PubMed ID: 10425642
[TBL] [Abstract][Full Text] [Related]
7. BN52021 stabilizes the oxidant-antioxidant equilibrium in peritoneal lavage fluid in experimental hemorrhagic shock.
Debek W; Chyczewski L; Farbiszewski R
Folia Histochem Cytobiol; 1999; 37(4):249-54. PubMed ID: 10598326
[TBL] [Abstract][Full Text] [Related]
8. Platelet-activating factor receptor-antagonist (BN 52021) stabilizes the oxidative-antioxidative balance and attenuates the morphological changes in the gastrointestinal tract in experimental hemorrhagic shock.
Debek W; Chyczewski L; Makarewicz M
Exp Toxicol Pathol; 1998 Mar; 50(1):19-25. PubMed ID: 9570497
[TBL] [Abstract][Full Text] [Related]
9. Effects of antioxidants and PAF receptor antagonist in intestinal shock in the rat.
Haglind E; Xia G; Rylander R
Circ Shock; 1994 Feb; 42(2):83-91. PubMed ID: 8013065
[TBL] [Abstract][Full Text] [Related]
10. Effect of a platelet-activating factor (PAF) receptor antagonist on hyperacute xenograft rejection; evaluation in a pig kidney-human blood xenoperfusion model.
Cruzado JM; Torras J; Riera M; Lloberas N; Herrero I; Condom E; Martorell J; Alsina J; Grinyó JM
Clin Exp Immunol; 1998 Jul; 113(1):136-44. PubMed ID: 9697996
[TBL] [Abstract][Full Text] [Related]
11. Effect of the platelet-activating factor (PAF) antagonist, BN 52021, on free radical-induced intestinal ischemia-reperfusion damage in the rat.
Droy-Lefaix MT; Drouet Y; Braquet P; Géraud G
Adv Exp Med Biol; 1990; 264():419-22. PubMed ID: 2244522
[No Abstract] [Full Text] [Related]
12. Platelet-activating factor antagonists as therapeutic strategy in sepsis.
Dhainaut JF; Mira JP; Brunet F
Prog Clin Biol Res; 1994; 388():277-93. PubMed ID: 7831364
[No Abstract] [Full Text] [Related]
13. Role of platelet-activating factor in long-term potentiation of the rat medial vestibular nuclei.
Grassi S; Francescangeli E; Goracci G; Pettorossi VE
J Neurophysiol; 1998 Jun; 79(6):3266-71. PubMed ID: 9636125
[TBL] [Abstract][Full Text] [Related]
14. Superoxide dismutase (SOD) and the PAF-antagonist (BN 52021) reduce small intestinal damage induced by ischemia-reperfusion.
Droy-Lefaix MT; Drouet Y; Geraud G; Hosford D; Braquet P
Free Radic Res Commun; 1991; 12-13 Pt 2():725-35. PubMed ID: 2060844
[TBL] [Abstract][Full Text] [Related]
15. Changes in cytosolic free calcium induced by platelet-activating factor in rabbit platelets: specific inhibition by BN 52021 and structurally related compounds.
Baroggi N; Etienne A; Braquet P
Agents Actions Suppl; 1986; 20():87-97. PubMed ID: 3028108
[TBL] [Abstract][Full Text] [Related]
16. Endothelium-dependent vasodilation in the isolated rabbit kidney following in vivo and in vitro ischaemia and reperfusion: effects of antagonizing platelet activating factor (PAF).
Uluoglu C; Timlioglu O
Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):324-30. PubMed ID: 10543435
[TBL] [Abstract][Full Text] [Related]
17. Involvement of oxygen free radicals in the action of BN 52021 (PAF antagonist) to limit myocardial infarct size.
Chopra K; Singh M; Gupta S; Ganguly NK
Methods Find Exp Clin Pharmacol; 1993 Sep; 15(7):437-45. PubMed ID: 8255122
[TBL] [Abstract][Full Text] [Related]
18. Interplay among platelet-activating factor, oxidative stress, and group I metabotropic glutamate receptors modulates neuronal survival.
Zhu P; DeCoster MA; Bazan NG
J Neurosci Res; 2004 Aug; 77(4):525-31. PubMed ID: 15264222
[TBL] [Abstract][Full Text] [Related]
19. Increase in the peritoneal antioxidative potential in experimental hemorrhagic shock.
Debek W; Chyczewski L; Dziecioł J; Farbiszewski R; Błahuszewski R
Rocz Akad Med Bialymst; 1995; 40(1):122-8. PubMed ID: 8528981
[TBL] [Abstract][Full Text] [Related]
20. [The effect of platelet-activating factor and its antagonist--BN 52021--on immune reactions in vivo in mice and in vitro].
Poveshchenko AF; Kozlov VA
Zh Mikrobiol Epidemiol Immunobiol; 1999; (4):53-6. PubMed ID: 10852052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
